The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.
Identifieur interne : 000025 ( PubMed/Corpus ); précédent : 000024; suivant : 000026The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.
Auteurs : Stéphane Lehericy ; David E. Vaillancourt ; Klaus Seppi ; Oury Monchi ; Irena Rektorova ; Angelo Antonini ; Martin J. Mckeown ; Mario Masellis ; Daniela Berg ; James B. Rowe ; Simon J G. Lewis ; Caroline H. Williams-Gray ; Alessandro Tessitore ; Hartwig R. SiebnerSource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2017.
Abstract
Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
DOI: 10.1002/mds.26968
PubMed: 28370449
Links to Exploration step
pubmed:28370449Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.</title><author><name sortKey="Lehericy, Stephane" sort="Lehericy, Stephane" uniqKey="Lehericy S" first="Stéphane" last="Lehericy">Stéphane Lehericy</name><affiliation><nlm:affiliation>Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillancourt, David E" sort="Vaillancourt, David E" uniqKey="Vaillancourt D" first="David E" last="Vaillancourt">David E. Vaillancourt</name><affiliation><nlm:affiliation>Department of Applied Physiology and Kinesiology, Department of Neurology and Centre for Movement Disorders and Neurorestoration, Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name><affiliation><nlm:affiliation>Department of Neurology, Medical University Innsbruck, Innsbruck, Austria and Neuroimaging Research Core Facility, Medical University Innsbruck, Innsbruck, Austria.</nlm:affiliation></affiliation></author><author><name sortKey="Monchi, Oury" sort="Monchi, Oury" uniqKey="Monchi O" first="Oury" last="Monchi">Oury Monchi</name><affiliation><nlm:affiliation>Department of Clinical Neurosciences, Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rektorova, Irena" sort="Rektorova, Irena" uniqKey="Rektorova I" first="Irena" last="Rektorova">Irena Rektorova</name><affiliation><nlm:affiliation>First Department of Neurology, School of Medicine, St. Anne's University Hospital, Brain and Mind Research Program, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.</nlm:affiliation></affiliation></author><author><name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name><affiliation><nlm:affiliation>Parkinson and Movement Disorders Unit, istituto di ricovero e cura a carattere scientifico (IRCCS) Hospital San Camillo, Venice and Department of Neurosciences (DNS), Padova University, Padova, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Mckeown, Martin J" sort="Mckeown, Martin J" uniqKey="Mckeown M" first="Martin J" last="Mckeown">Martin J. Mckeown</name><affiliation><nlm:affiliation>Pacific Parkinson's Research Center, Department of Medicine (Neurology), University of British Columbia Vancouver, BC, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Masellis, Mario" sort="Masellis, Mario" uniqKey="Masellis M" first="Mario" last="Masellis">Mario Masellis</name><affiliation><nlm:affiliation>Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation><nlm:affiliation>Department of Neurology, Christian-Albrechts-University of Kiel and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Rowe, James B" sort="Rowe, James B" uniqKey="Rowe J" first="James B" last="Rowe">James B. Rowe</name><affiliation><nlm:affiliation>Department of Clinical Neurosciences, Cambridge University, and Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Lewis, Simon J G" sort="Lewis, Simon J G" uniqKey="Lewis S" first="Simon J G" last="Lewis">Simon J G. Lewis</name><affiliation><nlm:affiliation>Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Williams Gray, Caroline H" sort="Williams Gray, Caroline H" uniqKey="Williams Gray C" first="Caroline H" last="Williams-Gray">Caroline H. Williams-Gray</name><affiliation><nlm:affiliation>John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Tessitore, Alessandro" sort="Tessitore, Alessandro" uniqKey="Tessitore A" first="Alessandro" last="Tessitore">Alessandro Tessitore</name><affiliation><nlm:affiliation>Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Siebner, Hartwig R" sort="Siebner, Hartwig R" uniqKey="Siebner H" first="Hartwig R" last="Siebner">Hartwig R. Siebner</name><affiliation><nlm:affiliation>Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Department of Neurology, Copenhagen University Hospital Bispebjerg, Hvidovre, Denmark.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28370449</idno><idno type="pmid">28370449</idno><idno type="doi">10.1002/mds.26968</idno><idno type="wicri:Area/PubMed/Corpus">000025</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000025</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.</title><author><name sortKey="Lehericy, Stephane" sort="Lehericy, Stephane" uniqKey="Lehericy S" first="Stéphane" last="Lehericy">Stéphane Lehericy</name><affiliation><nlm:affiliation>Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Vaillancourt, David E" sort="Vaillancourt, David E" uniqKey="Vaillancourt D" first="David E" last="Vaillancourt">David E. Vaillancourt</name><affiliation><nlm:affiliation>Department of Applied Physiology and Kinesiology, Department of Neurology and Centre for Movement Disorders and Neurorestoration, Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Seppi, Klaus" sort="Seppi, Klaus" uniqKey="Seppi K" first="Klaus" last="Seppi">Klaus Seppi</name><affiliation><nlm:affiliation>Department of Neurology, Medical University Innsbruck, Innsbruck, Austria and Neuroimaging Research Core Facility, Medical University Innsbruck, Innsbruck, Austria.</nlm:affiliation></affiliation></author><author><name sortKey="Monchi, Oury" sort="Monchi, Oury" uniqKey="Monchi O" first="Oury" last="Monchi">Oury Monchi</name><affiliation><nlm:affiliation>Department of Clinical Neurosciences, Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Rektorova, Irena" sort="Rektorova, Irena" uniqKey="Rektorova I" first="Irena" last="Rektorova">Irena Rektorova</name><affiliation><nlm:affiliation>First Department of Neurology, School of Medicine, St. Anne's University Hospital, Brain and Mind Research Program, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.</nlm:affiliation></affiliation></author><author><name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name><affiliation><nlm:affiliation>Parkinson and Movement Disorders Unit, istituto di ricovero e cura a carattere scientifico (IRCCS) Hospital San Camillo, Venice and Department of Neurosciences (DNS), Padova University, Padova, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Mckeown, Martin J" sort="Mckeown, Martin J" uniqKey="Mckeown M" first="Martin J" last="Mckeown">Martin J. Mckeown</name><affiliation><nlm:affiliation>Pacific Parkinson's Research Center, Department of Medicine (Neurology), University of British Columbia Vancouver, BC, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Masellis, Mario" sort="Masellis, Mario" uniqKey="Masellis M" first="Mario" last="Masellis">Mario Masellis</name><affiliation><nlm:affiliation>Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</nlm:affiliation></affiliation></author><author><name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name><affiliation><nlm:affiliation>Department of Neurology, Christian-Albrechts-University of Kiel and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.</nlm:affiliation></affiliation></author><author><name sortKey="Rowe, James B" sort="Rowe, James B" uniqKey="Rowe J" first="James B" last="Rowe">James B. Rowe</name><affiliation><nlm:affiliation>Department of Clinical Neurosciences, Cambridge University, and Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Lewis, Simon J G" sort="Lewis, Simon J G" uniqKey="Lewis S" first="Simon J G" last="Lewis">Simon J G. Lewis</name><affiliation><nlm:affiliation>Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Sydney, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Williams Gray, Caroline H" sort="Williams Gray, Caroline H" uniqKey="Williams Gray C" first="Caroline H" last="Williams-Gray">Caroline H. Williams-Gray</name><affiliation><nlm:affiliation>John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Tessitore, Alessandro" sort="Tessitore, Alessandro" uniqKey="Tessitore A" first="Alessandro" last="Tessitore">Alessandro Tessitore</name><affiliation><nlm:affiliation>Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy.</nlm:affiliation></affiliation></author><author><name sortKey="Siebner, Hartwig R" sort="Siebner, Hartwig R" uniqKey="Siebner H" first="Hartwig R" last="Siebner">Hartwig R. Siebner</name><affiliation><nlm:affiliation>Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Department of Neurology, Copenhagen University Hospital Bispebjerg, Hvidovre, Denmark.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28370449</PMID><DateCreated><Year>2017</Year><Month>04</Month><Day>03</Day></DateCreated><DateRevised><Year>2017</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.</ArticleTitle><Pagination><MedlinePgn>510-525</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.26968</ELocationID><Abstract><AbstractText>Historically, magnetic resonance imaging (MRI) has contributed little to the study of Parkinson's disease (PD), but modern MRI approaches have unveiled several complementary markers that are useful for research and clinical applications. Iron- and neuromelanin-sensitive MRI detect qualitative changes in the substantia nigra. Quantitative MRI markers can be derived from diffusion weighted and iron-sensitive imaging or volumetry. Functional brain alterations at rest or during task performance have been captured with functional and arterial spin labeling perfusion MRI. These markers are useful for the diagnosis of PD and atypical parkinsonism, to track disease progression from the premotor stages of these diseases and to better understand the neurobiological basis of clinical deficits. A current research goal using MRI is to generate time-dependent models of the evolution of PD biomarkers that can help understand neurodegeneration and provide reliable markers for therapeutic trials. This article reviews recent advances in MRI biomarker research at high-field (3T) and ultra high field-imaging (7T) in PD and atypical parkinsonism. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</AbstractText><CopyrightInformation>© 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lehericy</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institut du Cerveau et de la Moelle épinière - ICM, Centre de NeuroImagerie de Recherche - CENIR, Sorbonne Universités, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaillancourt</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Applied Physiology and Kinesiology, Department of Neurology and Centre for Movement Disorders and Neurorestoration, Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seppi</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University Innsbruck, Innsbruck, Austria and Neuroimaging Research Core Facility, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monchi</LastName><ForeName>Oury</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Department of Radiology, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rektorova</LastName><ForeName>Irena</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>First Department of Neurology, School of Medicine, St. Anne's University Hospital, Brain and Mind Research Program, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonini</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Parkinson and Movement Disorders Unit, istituto di ricovero e cura a carattere scientifico (IRCCS) Hospital San Camillo, Venice and Department of Neurosciences (DNS), Padova University, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKeown</LastName><ForeName>Martin J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Pacific Parkinson's Research Center, Department of Medicine (Neurology), University of British Columbia Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masellis</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Christian-Albrechts-University of Kiel and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowe</LastName><ForeName>James B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurosciences, Cambridge University, and Medical Research Council Cognition and Brain Sciences Unit, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Simon J G</ForeName><Initials>SJG</Initials><AffiliationInfo><Affiliation>Parkinson's Disease Research Clinic, Brain and Mind Centre, University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams-Gray</LastName><ForeName>Caroline H</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tessitore</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebner</LastName><ForeName>Hartwig R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Department of Neurology, Copenhagen University Hospital Bispebjerg, Hvidovre, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">7T</Keyword><Keyword MajorTopicYN="N">MRI</Keyword><Keyword MajorTopicYN="N">Parkinson's disease</Keyword><Keyword MajorTopicYN="N">atypical parkinsonism</Keyword><Keyword MajorTopicYN="N">diffusion MRI</Keyword><Keyword MajorTopicYN="N">fMRI</Keyword><Keyword MajorTopicYN="N">iron</Keyword><Keyword MajorTopicYN="N">neuromelanin</Keyword><Keyword MajorTopicYN="N">resting state fMRI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28370449</ArticleId><ArticleId IdType="doi">10.1002/mds.26968</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000025 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000025 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28370449
|texte= The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28370449" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |